|
US6339173B1
(en)
*
|
1996-07-22 |
2002-01-15 |
Promega Biosciences, Inc. |
Amide-based cationic lipids
|
|
FR2760193B1
(fr)
|
1997-02-28 |
1999-05-28 |
Transgene Sa |
Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
|
|
US5877220A
(en)
*
|
1997-03-06 |
1999-03-02 |
Genta, Incorporated |
Amide-based oligomeric cationic lipids
|
|
US6034135A
(en)
*
|
1997-03-06 |
2000-03-07 |
Promega Biosciences, Inc. |
Dimeric cationic lipids
|
|
US6395713B1
(en)
*
|
1997-07-23 |
2002-05-28 |
Ribozyme Pharmaceuticals, Inc. |
Compositions for the delivery of negatively charged molecules
|
|
WO1999008997A1
(de)
*
|
1997-08-13 |
1999-02-25 |
Biontex Laboratories Gmbh |
Neue lipopolyamine, deren darstellung und anwendung
|
|
GB9914045D0
(en)
|
1999-06-16 |
1999-08-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP1242609A2
(en)
*
|
1999-12-30 |
2002-09-25 |
Novartis AG |
Novel colloid synthetic vectors for gene therapy
|
|
US6686461B1
(en)
*
|
2000-03-22 |
2004-02-03 |
Solulink Bioscience, Inc. |
Triphosphate oligonucleotide modification reagents and uses thereof
|
|
AU2001247697B2
(en)
*
|
2000-03-22 |
2006-06-22 |
Solulink, Incorporated |
Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
|
|
US7102024B1
(en)
|
2000-08-01 |
2006-09-05 |
Schwartz David A |
Functional biopolymer modification reagents and uses thereof
|
|
US7294511B2
(en)
*
|
2001-03-22 |
2007-11-13 |
Chromos Molecular Systems, Inc. |
Methods for delivering nucleic acid molecules into cells and assessment thereof
|
|
DE10117043A1
(de)
*
|
2001-04-05 |
2002-11-07 |
Gerhard Puetz |
Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
|
|
US20070141724A1
(en)
*
|
2003-07-29 |
2007-06-21 |
Schmidt Jurgen G |
Solid phase immobilized trifunctional linker
|
|
CN1882693B
(zh)
|
2003-09-15 |
2012-08-15 |
普洛体维生物治疗公司 |
聚乙二醇修饰的脂质化合物及其应用
|
|
US7158353B2
(en)
*
|
2003-11-06 |
2007-01-02 |
Seagate Technology Llc |
Magnetoresistive sensor having specular sidewall layers
|
|
US7142948B2
(en)
|
2004-01-07 |
2006-11-28 |
Honeywell International Inc. |
Controller interface with dynamic schedule display
|
|
DK1771206T3
(en)
*
|
2004-05-05 |
2018-05-22 |
Silence Therapeutics Gmbh |
LIPIDS, LIPID COMPLEXES AND USE THEREOF
|
|
CA2569664C
(en)
*
|
2004-06-07 |
2013-07-16 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
|
US20060134189A1
(en)
*
|
2004-11-17 |
2006-06-22 |
Protiva Biotherapeutics, Inc |
siRNA silencing of apolipoprotein B
|
|
BRPI0519468A2
(pt)
|
2004-12-27 |
2009-01-27 |
Silence Therapeutics Ag |
complexos de lipÍdeos revestido e seu uso
|
|
EP1948674A4
(en)
|
2005-11-02 |
2009-02-04 |
Protiva Biotherapeutics Inc |
MODIFIED SIRNA MOLECULES AND APPLICATIONS THEREOF
|
|
BRPI0714875A2
(pt)
|
2006-07-21 |
2013-05-28 |
Silence Therapeutics Ag |
meios para inibir a expressço da proteÍna cinase 3
|
|
EP2091914A4
(en)
*
|
2006-11-08 |
2010-12-29 |
Chongxi Yu |
TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
|
|
US9006191B2
(en)
*
|
2007-12-27 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering RNA
|
|
EP3100718B1
(en)
*
|
2008-01-02 |
2019-11-27 |
Arbutus Biopharma Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
EP2279254B1
(en)
|
2008-04-15 |
2017-07-05 |
Protiva Biotherapeutics Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
AU2009303345B2
(en)
|
2008-10-09 |
2015-08-20 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
EP2405921A4
(en)
|
2009-01-26 |
2013-05-22 |
Protiva Biotherapeutics Inc |
COMPOSITIONS AND METHODS FOR VAPORING APOLIPOPROTIEN C-III EXPRESSION
|
|
EP2660247A3
(en)
|
2009-05-08 |
2014-09-03 |
Chongxi Yu |
High penetration prodrug compositions of peptides and peptide-related compounds
|
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
ES2613498T3
(es)
|
2009-07-01 |
2017-05-24 |
Protiva Biotherapeutics Inc. |
Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos
|
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
WO2011011447A1
(en)
|
2009-07-20 |
2011-01-27 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus gene expression
|
|
US8455455B1
(en)
|
2010-03-31 |
2013-06-04 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes involved in hemorrhagic fever
|
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
|
ES2702428T3
(es)
*
|
2010-11-15 |
2019-02-28 |
Life Technologies Corp |
Reactivos de transfección que contienen amina y métodos para prepararlos y usarlos
|
|
AU2012325997C1
(en)
*
|
2011-10-18 |
2018-07-05 |
Dicerna Pharmaceuticals, Inc. |
Amine cationic lipids and uses thereof
|
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
|
JP5970439B2
(ja)
*
|
2013-09-20 |
2016-08-17 |
チョンシー ユー |
ペプチド及び関連化合物の経皮送達システム
|
|
CA2953341C
(en)
|
2014-06-25 |
2023-01-24 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
WO2016176330A1
(en)
|
2015-04-27 |
2016-11-03 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
HUE067372T2
(hu)
|
2015-06-29 |
2024-10-28 |
Acuitas Therapeutics Inc |
Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
|
|
CN108368028B
(zh)
|
2015-10-28 |
2021-09-03 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
|
US12678515B2
(en)
|
2015-12-30 |
2026-07-14 |
Acuitas Therapeutics, Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
CN108699096B
(zh)
*
|
2016-02-22 |
2021-11-26 |
赢创运营有限公司 |
用于头发香味保留的鼠李糖脂酰胺
|
|
US12491261B2
(en)
|
2016-10-26 |
2025-12-09 |
Acuitas Therapeutics, Inc. |
Lipid nanoparticle formulations
|
|
EP3568155A4
(en)
|
2017-01-11 |
2020-09-23 |
The Trustees Of The University Of Pennsylvania |
RNA MODIFIED BY NUCLEOSIDE TO INDUCE AN IMMUNE RESPONSE AGAINST ZIKA VIRUS
|
|
US11357856B2
(en)
|
2017-04-13 |
2022-06-14 |
Acuitas Therapeutics, Inc. |
Lipids for delivery of active agents
|
|
US11820728B2
(en)
|
2017-04-28 |
2023-11-21 |
Acuitas Therapeutics, Inc. |
Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
WO2018209130A1
(en)
|
2017-05-11 |
2018-11-15 |
Tc1 Llc |
Thermal interconnect for implantable blood pump
|
|
JP7355731B2
(ja)
|
2017-08-16 |
2023-10-03 |
アクイタス セラピューティクス インコーポレイテッド |
脂質ナノ粒子製剤における使用のための脂質
|
|
JP7461872B2
(ja)
|
2017-08-17 |
2024-04-04 |
アクイタス セラピューティクス インコーポレイテッド |
脂質ナノ粒子製剤における使用のための脂質
|
|
WO2019036028A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
|
|
US11524932B2
(en)
|
2017-08-17 |
2022-12-13 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
EP3852911B1
(en)
|
2018-09-21 |
2025-01-22 |
Acuitas Therapeutics, Inc. |
Systems and methods for manufacturing lipid nanoparticles and liposomes
|
|
CA3116576A1
(en)
*
|
2018-10-18 |
2020-04-23 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
PL3908568T3
(pl)
|
2019-01-11 |
2024-12-02 |
Acuitas Therapeutics, Inc. |
Lipidy do dostarczania środków czynnych w nanocząstkach lipidowych
|
|
CA3178344A1
(en)
|
2020-03-31 |
2021-10-07 |
The Trustees Of The University Of Pennsylvania |
Universal influenza vaccine using nucleoside-modified mrna
|
|
EP4178544A4
(en)
|
2020-07-08 |
2024-09-25 |
The Trustees of the University of Pennsylvania |
NUCLEOSIDE-MODIFIED RNA TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV-2 VIRUS
|
|
KR20230051172A
(ko)
|
2020-07-16 |
2023-04-17 |
아퀴타스 테라퓨틱스 인크. |
지질 나노 입자에 사용하기 위한 양이온성 지질
|
|
CN117098541A
(zh)
|
2020-11-25 |
2023-11-21 |
阿卡格拉医药公司 |
用于递送核酸的脂质纳米粒及相关使用方法
|
|
WO2023114943A2
(en)
|
2021-12-16 |
2023-06-22 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2023230587A2
(en)
|
2022-05-25 |
2023-11-30 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
|
|
EP4534525A4
(en)
*
|
2022-06-02 |
2025-08-20 |
Xiamen Sinopeg Biotech Co Ltd |
CATIONIC LIPID BASED ON AMINO ACIDS CONTAINING UNSATURATED BONDS
|
|
CN120737002A
(zh)
*
|
2022-06-02 |
2025-10-03 |
厦门赛诺邦格生物科技股份有限公司 |
一种氨基酸阳离子脂质
|
|
WO2024034178A1
(ja)
*
|
2022-08-12 |
2024-02-15 |
Tdk株式会社 |
溶媒中抗原回収システム及び溶媒中抗原回収方法
|
|
US12691068B2
(en)
*
|
2022-12-27 |
2026-07-28 |
Sun Vax mRNA Therapeutics Inc. |
Modular lipid compounds and two- to three-component lipid nanoparticle compositions
|
|
CN119562942A
(zh)
*
|
2023-06-30 |
2025-03-04 |
厦门赛诺邦格生物科技股份有限公司 |
一种含有两个叔胺基团的阳离子脂质及其应用
|